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COVID-19 testing strategies are primarily driven by medical need - focusing on people already 
hospitalized with significant symptoms or on people most at risk. However, such testing is 
highly biased because it fails to identify the extent to which COVID-19 is present in people 
with mild or no symptoms.  If we wish to understand the true rate of COVID-19 infection and 
death, we need to take full account of the causal explanations for the resulting data to avoid 
highly misleading conclusions about infection and death rates. We describe how causal 
(Bayesian network) models can provide such explanations and the need to combine these 
with more random testing in order to achieve reliable data and predictions for the both policy 




Misleading death rates 
Suppose we wanted to estimate how many car owners there are in the UK and how many of 
those own a Ford Fiesta, but we only have sampled data on those people who visited Ford 
Car Showrooms in the last year. If 9% of the showroom visitors owned a Fiesta then, because 
of this selection bias in the sampled data, this would certainly overestimate the proportion of 
Ford Fiesta owners in the country. Estimating death rates for people with COVID-19 is 
currently undertaken largely along the same lines. 
Take the UK as an example, here all testing of COVID-19 is performed on people already 
hospitalized with COVID-19 symptoms. At the time of writing1, there were - according to the 
official NHS reporting figures - 33,722 confirmed COVID-19 cases (analogous to car owners 
visiting a showroom) of whom 2,921 have died (Ford Fiesta owners who visited a showroom). 
Concluding that the death rate from COVID-19 is on average 9% (2,921 out of 33,722) ignores 
the many people with COVID-19 who are not hospitalized and have not died (analogous to 
car owners who did not visit a Ford showroom and who do not own a Ford Fiesta). It is 
therefore equivalent to making the mistake of concluding that 9% of all car owners own a 
Ford Fiesta.  
There are many prominent examples of this sort of erroneous conclusion. The Oxford COVID-
19 Evidence Service (Oke & Heneghan, 2020) have undertaken a thorough statistical analysis. 
They acknowledge potential selection bias, but for them ‘uncertainty’ takes the form of 
confidence bounds around the (potentially highly misleading) proportion of deaths among 
confirmed COVID-19 patients. They also note various factors that can result in wide national 
differences, such as different demographic factors and differences in the way deaths are 





9% (mean) ‘death rate’ is so high compared to Germany’s 0.74%. We know that in the UK 
currently everybody who dies with COVID-19 is recorded as a COVID-19 death, even if the 
disease was not the actual cause of death; but it is also possible that people may die from the 
virus without actually having been diagnosed with COVID-19 (Henriques, 2020). 
The fact that all the uncertainty around the death rates remains l anchored around one 
statistic, reported deaths per confirmed cases, is awkward. It fails to incorporate explicit 
causal explanations that might enable us to make more meaningful inferences from the 
available data, including data on virus testing. To do this we need explicit causal/graphical 
models (Pearl & Mackenzie, 2018). 
The need for a causal model 
Figure 1 is an example of a causal model, represented by a graph (called a Bayesian network), 
that might be applicable to any given country and its population. It shows that the COVID-19 
death rate is as much a function of sampling methods, testing and reporting, as it is 




Figure 1 Causal Bayesian network model for learning population COVID-19 infected and death 
rates. This is a single time slice. It is can be updated daily and so enables us also to learn the 
true rate of spread of the infection. ‘With symptoms’ means serious symptoms. 
The links between the variables in the model (nodes in graph) show how they are dependent 
on each other. For example, the “population proportion with COVID-19 who die” is dependent 
on “population demographics and environmental factors” as well as “Quality of healthcare” 
(which might cover factors such as intensive care unit capacity etc). Note that the model 
carefully distinguishes between whether or not a person really has COVID-19 and whether 
the person is classified as having COVID-19 (i.e. the model takes account of the potential for 
false positive and false negative test results). So, for example, the variable “Number of 
reported COVID-19 positive reported as died” (which is the official figure of ‘COVID-19 deaths 
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reported) is dependent on the actual “Population proportion with COVID-19 who die”, the 
“Death Reporting Policy” as well as several other variables including “Number tested positive 
with symptoms who do not have COVID-19”.  
The strength of each dependency, as well as the uncertainty associated with these is captured 
using probabilities and statistical distributions. When observed data is entered into the model 
for specific variables that are subsequently observed all of the probabilities for, as yet, 
unknown variable are updated using an AI algorithm called Bayesian inference. The model in 
Figure 1 is more accurately called a (causal) Bayesian network (Fenton & Neil, 2018), because 
it explains the underlying process by which the observed data might be generated. We have 
developed such models for many similar problems and are currently gathering the data 
needed to determine this causal model. 
Therefore, while clinical, demographic and environmental factors can lead to genuine 
differences in death rates shown across different countries, very large differences may be 
likely to be caused by the application of different sampling strategies and reporting policies 
(Binnicker, 2020; FindX, 2020) and not necessarily because they are managing the virus any 
better or that the virus has infected fewer or more people. With a causal model that explains 
the data generating process we might better account for these differences between countries 
and more accurately learn the underlying true population infection and death rates from the 
observed data.  
 
The need for more random testing 
In the absence of community-wide testing, only random testing, applied throughout the 
population, will help us learn the number of people with COVID-19 who are asymptomatic or 
have already recovered, and hence also estimate the underlying infection and death rates. It 
will also help us learn the accuracy of the testing undertaken (false positive, and false negative 
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rates). Random testing remains the most effective strategy to avoid selection bias and reduce 
the distortions in reported statistics, but it also needs to be combined with a causal model in 
order to better determine the prevalence, severity, and ultimately societal impact of COVID-
19.  
Currently it seems there are no state-wide protocols in place in any country for randomised 
community testing of citizens for COVID-19. Spain did attempt it, but that involved purchasing 
large volumes of rapid COVID-19 tests, and they soon discovered that some Chinese-sourced 
tests had poor validity and reliability delivering only 30% accuracy – resulting in high numbers 
of false positives. Countries like Norway have proposed introducing such tests, but there is 
uncertainty around how to legislatively compel citizens to test – and what might constitute 
an appropriate randomisation protocol. In Iceland, they have voluntary sampling which has 
covered 3% of the population, but this isn’t random. Some countries with large scale testing, 
like South Korea, might get closer to being random. 
The reason it is so hard to achieve random testing is that you have to account for several 
practical and psychological factors. How does one collect samples randomly? Gathering 
samples from volunteers may not be sufficient as it does not prevent self-selection bias. 
During the H1N1 influenza pandemic of 2009–2010, there was a lot of anxiety about the 
disease that created “mass psychogenic illness” (Wheaton, Abramowitz, Berman, Fabricant, 
& Olatunji, 2012). This is when hypersensitivity to particular symptoms leads to healthy 
people self-diagnosing as having a virus – meaning they would be highly incentivised to get 
tested. This could, in part, further contribute to false positive rates if the sensitivity and 
specificity of the tests are not fully understood. 
While self-selection bias is not going to be eliminated, it could be reduced by running field 
tests. This could involve asking the public to volunteer samples in locations where, even in a 
lockdown state, they might be expected to attend and also from those in self-imposed 
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isolation or quarantine. In any event, when statistics are communicated at press conferences 
or in the media, their limitations should be explained and any relevance to the individual or 
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